What does albumin in urinalysis mean?

Albumin in urinalysis indicates protein leaking from kidneys into urine, which can signal kidney damage or disease. Normal levels are below 30 mg/g, while higher levels may indicate conditions ranging from temporary stress to chronic kidney disease.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Albumin and Its Role in Your Body

Albumin is the most abundant protein in your blood, making up about 60% of total blood proteins. Produced by your liver, this essential protein serves multiple critical functions: it maintains fluid balance by preventing blood from leaking out of vessels, transports hormones and medications throughout your body, and helps regulate blood pressure. Under normal circumstances, your kidneys act as sophisticated filters that keep albumin in your bloodstream while allowing waste products to pass into urine.

When albumin appears in your urine, it's called albuminuria or proteinuria. This occurs when your kidney's filtering units, called glomeruli, become damaged or inflamed and allow proteins to leak through. Think of your kidneys as a coffee filter - when working properly, they keep the coffee grounds (proteins) in while letting liquid pass through. But when the filter develops holes, grounds start seeping into your cup.

Normal vs. Abnormal Albumin Levels in Urine

Understanding what constitutes normal versus abnormal albumin levels in urine is crucial for interpreting your test results. The measurement is typically expressed as the albumin-to-creatinine ratio (ACR), which accounts for urine concentration variations throughout the day.

Albumin-to-Creatinine Ratio (ACR) Categories

ACR results should be confirmed with repeat testing and interpreted alongside other kidney function markers and clinical symptoms.
ACR Level (mg/g)CategoryClinical SignificanceRecommended Action
<30Less than 30 mg/gNormalHealthy kidney functionContinue routine monitoring
30-30030-300 mg/gModerately increased (Microalbuminuria)Early kidney damage, increased cardiovascular riskConfirm with repeat testing, address risk factors
>300Greater than 300 mg/gSeverely increased (Macroalbuminuria)Advanced kidney damage, high cardiovascular riskImmediate medical evaluation and treatment

ACR results should be confirmed with repeat testing and interpreted alongside other kidney function markers and clinical symptoms.

Interpreting Your Results

A single elevated reading doesn't necessarily indicate kidney disease. Your healthcare provider will typically request repeat testing to confirm persistent albuminuria. Factors like recent exercise, fever, or urinary tract infections can temporarily elevate albumin levels. However, consistently elevated levels warrant further investigation and monitoring.

Common Causes of Albumin in Urine

Albumin in urine can result from various conditions, ranging from temporary situations to chronic diseases. Understanding these causes helps determine the appropriate response and treatment approach.

Temporary Causes

  • Strenuous exercise: Intense physical activity can temporarily increase albumin excretion
  • Fever or acute illness: Body stress can affect kidney filtration
  • Dehydration: Concentrated urine may show higher albumin levels
  • Urinary tract infections: Inflammation can cause temporary protein leakage
  • Orthostatic proteinuria: Some people excrete more protein when standing

Chronic Conditions

  • Diabetes: High blood sugar damages kidney blood vessels over time
  • Hypertension: Elevated blood pressure strains kidney filtration units
  • Chronic kidney disease: Progressive kidney damage increases albumin leakage
  • Glomerulonephritis: Inflammation of kidney filtering units
  • Autoimmune diseases: Conditions like lupus can affect kidney function

The Connection Between Albumin and Kidney Health

Albumin in urine serves as an early warning system for kidney damage. Your kidneys contain approximately one million tiny filtering units called nephrons. Each nephron has a glomerulus that acts as a selective barrier, allowing waste products to pass while retaining essential proteins like albumin. When these filters become damaged, they lose their selectivity, allowing albumin to escape into the urine.

The presence of albumin in urine often precedes other signs of kidney dysfunction by years or even decades. This makes albumin testing a valuable screening tool for early detection of kidney disease, particularly in high-risk populations such as people with diabetes or hypertension. Early detection allows for interventions that can slow or prevent progression to more severe kidney damage.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Testing Methods and Frequency

Several testing methods can detect and measure albumin in urine, each with specific advantages and applications. Understanding these options helps you work with your healthcare provider to choose the most appropriate monitoring approach.

Types of Albumin Tests

  • Urine dipstick test: Quick screening tool that provides qualitative results
  • Spot urine albumin-to-creatinine ratio (ACR): Most common test using a single urine sample
  • 24-hour urine collection: Gold standard but less convenient, measures total daily albumin excretion
  • Timed urine collection: Shorter collection periods (4-8 hours) for specific situations

For most people, the spot urine ACR test offers the best balance of accuracy and convenience. This test can be performed at any time of day, though first-morning samples are often preferred as they're more concentrated. If you're monitoring your kidney health regularly, comprehensive testing that includes albumin along with other kidney function markers provides the most complete picture.

Managing and Reducing Albumin in Urine

If your urinalysis shows elevated albumin levels, several strategies can help protect your kidney function and potentially reduce protein excretion. The approach depends on the underlying cause and severity of albuminuria.

Lifestyle Modifications

  • Blood pressure control: Maintain levels below 130/80 mmHg through diet, exercise, and medication if needed
  • Blood sugar management: For diabetics, keep HbA1c below 7% or as recommended by your doctor
  • Dietary changes: Reduce sodium intake to less than 2,300 mg daily and moderate protein consumption
  • Weight management: Achieve and maintain a healthy BMI to reduce kidney strain
  • Smoking cessation: Tobacco use accelerates kidney damage progression

Medical Interventions

Your healthcare provider may prescribe medications to protect kidney function and reduce albumin excretion. ACE inhibitors and ARBs (angiotensin receptor blockers) are first-line treatments that lower blood pressure and have specific kidney-protective effects. SGLT2 inhibitors, originally developed for diabetes, have shown remarkable benefits for reducing albuminuria even in non-diabetic patients. Regular monitoring helps assess treatment effectiveness and adjust therapy as needed.

When to Seek Medical Attention

While occasional trace amounts of albumin in urine may not be concerning, certain situations warrant prompt medical evaluation. Contact your healthcare provider if you experience any of the following symptoms alongside abnormal urinalysis results:

  • Foamy or frothy urine that persists
  • Swelling in feet, ankles, or around eyes
  • Unexplained fatigue or weakness
  • Changes in urination frequency or volume
  • Blood in urine or dark-colored urine
  • Persistent high blood pressure
  • Unexplained weight gain from fluid retention

Additionally, if you have risk factors for kidney disease such as diabetes, hypertension, family history of kidney disease, or are over age 60, regular screening for albuminuria becomes even more important. Early detection and intervention can significantly slow disease progression.

The Importance of Regular Monitoring

Albumin levels in urine can fluctuate based on various factors, making regular monitoring essential for accurate assessment of kidney health. A single elevated reading doesn't necessarily indicate chronic kidney disease, but patterns over time provide valuable insights into kidney function trends.

For individuals with diabetes or hypertension, annual screening for albuminuria is recommended starting at diagnosis. Those with established kidney disease or persistent albuminuria may need more frequent monitoring, typically every 3-6 months. This regular testing allows for timely adjustments to treatment plans and helps track the effectiveness of interventions.

If you're concerned about your kidney health or want to establish a baseline for future comparison, consider getting your albumin levels tested along with other important health markers. Understanding your current status empowers you to take proactive steps toward maintaining optimal kidney function. For a free analysis of your existing lab results, including albumin and other kidney function markers, you can use SiPhox Health's blood test upload service to get personalized insights and recommendations.

Taking Control of Your Kidney Health

Finding albumin in your urinalysis can feel concerning, but it's important to remember that early detection provides an opportunity for intervention. Many people with microalbuminuria never progress to more severe kidney disease, especially when they take proactive steps to protect their kidney function.

The key lies in understanding what your results mean, working closely with your healthcare provider to address underlying causes, and implementing lifestyle changes that support kidney health. Regular monitoring, whether through traditional urinalysis or comprehensive biomarker testing, ensures you stay informed about your kidney function and can respond quickly to any changes.

Remember that your kidneys play a vital role in maintaining overall health, filtering waste products, regulating blood pressure, and producing essential hormones. By paying attention to early warning signs like albumin in urine and taking appropriate action, you're investing in your long-term health and well-being. With proper management and monitoring, many people with albuminuria maintain excellent kidney function for decades.

References

  1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International, 105(4S), S117-S314.[Link][DOI]
  2. Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165-180.[Link][PubMed][DOI]
  3. American Diabetes Association. (2023). Standards of Medical Care in Diabetes-2023. Diabetes Care, 46(Supplement 1), S191-S202.[Link][DOI]
  4. Heerspink, H. J., & Gansevoort, R. T. (2019). Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view. Clinical Journal of the American Society of Nephrology, 14(4), 561-563.[PubMed][DOI]
  5. Perkovic, V., et al. (2019). Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. New England Journal of Medicine, 380(24), 2295-2306.[Link][PubMed][DOI]
  6. Gansevoort, R. T., et al. (2013). Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney International, 84(1), 179-185.[PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my albumin at home?

You can test your albumin at home with SiPhox Health's Heart & Metabolic Program. This CLIA-certified program includes comprehensive kidney function testing with albumin measurements, providing lab-quality results from the comfort of your home.

What is the normal range for albumin in urine?

Normal albumin levels in urine are less than 30 mg/g when measured as albumin-to-creatinine ratio (ACR). Levels between 30-300 mg/g indicate moderately increased albuminuria (microalbuminuria), while levels above 300 mg/g suggest severely increased albuminuria (macroalbuminuria).

Can albumin in urine be reversed?

In many cases, albumin in urine can be reduced or reversed, especially when caught early. Treatment depends on the underlying cause but often includes blood pressure control, blood sugar management, dietary changes, and medications like ACE inhibitors or ARBs that protect kidney function.

How often should I test for albumin in urine?

Testing frequency depends on your risk factors and current health status. People with diabetes or hypertension should test annually. Those with known kidney disease or persistent albuminuria typically need testing every 3-6 months to monitor progression and treatment effectiveness.

What's the difference between albumin and protein in urine?

Albumin is a specific type of protein and the most common one found in urine when kidneys are damaged. Total protein in urine includes albumin plus other proteins. Albumin testing is more sensitive for early kidney damage detection, while total protein testing may identify other kidney or urinary tract issues.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details